Sec Form 4 Filing - STANGER KENT W @ MERIT MEDICAL SYSTEMS INC - 2014-06-05

Insider filing report for Changes in Beneficial Ownership
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
FORM 4
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Expires: November 30, 2011
Estimated average burden hours per response... 0.5
1. Name and Address of Reporting Person
STANGER KENT W
2. Issuer Name and Ticker or Trading Symbol
MERIT MEDICAL SYSTEMS INC [ MMSI]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X __ Director _____ 10% Owner
X __ Officer (give title below) _____ Other (specify below)
Chief Financial Officer
(Last) (First) (Middle)
1600 W MERIT PARKWAY
3. Date of Earliest Transaction (MM/DD/YY)
06/05/2014
(Street)
SOUTH JORDAN, UT84095
4. If Amendment, Date Original Filed (MM/DD/YY)
6. Individual or Joint/Group Filing (Check Applicable Line)
__ X __ Form filed by One Reporting Person
_____ Form filed by More than One Reporting Person
(City) (State) (Zip)
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Transaction Date (MM/DD/YY) 2A. Deemed Execution Date, if any (MM/DD/YY) 3. Transaction Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I)
(Instr. 4)
7. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V Amount (A) or (D) Price
Common Stock, No Par Value 79,100 I By 401(k) plan ( 1 )
Common Stock, No Par Value 4,271 ( 2 ) D
Common Stock, No Par Value 60,001 I Family Limited Liability Company ( 3 )
Common Stock, No Par Value 06/05/2014 M 10,165 A $ 9.7 725,001 D
Common Stock, No Par Value 06/05/2014 S 10,165 D $ 14.1086 ( 4 ) 714,836 D
Common Stock, No Par Value 06/06/2014 M 3,768 A $ 9.7 718,604 D
Common Stock, No Par Value 06/06/2014 S 3,768 D $ 14.1045 ( 5 ) 714,836 D
Common Stock, No Par Value 06/09/2014 M 8,204 A $ 9.7 723,040 D
Common Stock, No Par Value 06/09/2014 S 8,204 D $ 14.1201 ( 6 ) 714,836 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (MM/DD/YY) 3A. Deemed Execution Date, if any (MM/DD/YY) 4. Transaction Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4, and 5)
6. Date Exercisable and Expiration Date
(MM/DD/YY)
7. Title and Amount of Underlying Securities
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 4)
10. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 4)
11. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Non-qualified stock options (right to buy) $ 12.02 12/18/2004 12/18/2014 Common Stock 25,000 25,000 D
Non-qualified stock options (right to buy) $ 11.41 05/25/2005 05/25/2015 Common Stock 18,750 18,750 D
Non-qualified stock options (right to buy) $ 9.71 12/28/2005 12/28/2015 Common Stock 25,000 25,000 D
Non-qualified stock options (right to buy) $ 9.7 06/05/2014 M 10,165 06/27/2008( 7 ) 06/27/2014 Common Stock 10,165 $ 0 11,972 D
Non-qualified stock options (right to buy) $ 9.7 06/06/2014 M 3,768 06/27/2008( 7 ) 06/27/2014 Common Stock 3,768 $ 0 8,204 D
Non-qualified stock options (right to buy) $ 9.7 06/09/2014 M 8,204 06/27/2008( 7 ) 06/27/2014 Common Stock 8,204 $ 0 0 D
Non-qualified stock options (right to buy) $ 11.53 05/21/2009( 8 ) 05/21/2015 Common Stock 43,750 43,750 D
Non-qualified stock options (right to buy) $ 13.82 09/26/2010( 9 ) 09/26/2016 Common Stock 25,000 25,000 D
Non-qualified stock options (right to buy) $ 13.75 08/11/2012( 10 ) 08/11/2018 Common Stock 80,000 80,000 D
Reporting Owners
Reporting Owner Name / Address Relationships
Director 10% Owner Officer Other
STANGER KENT W
1600 W MERIT PARKWAY
SOUTH JORDAN, UT84095
X Chief Financial Officer
Signatures
Kent W. Stanger 06/09/2014
Signature of Reporting Person Date
Explanation of Responses:
( 1 )Represents plan holdings as of 06/09/2014.
( 2 )Employee stock purchase plan holdings as of 06/05/2014.
( 3 )This report shall not be deemed an admission that the reporting person is the beneficial owner of the securities held by K.W.S. Properties LC.
( 4 )The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.10 to $14.13, inclusive. The reporting person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
( 5 )The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.10 to $14.12, inclusive. The reporting person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
( 6 )The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.10 to $14.15, inclusive. The reporting person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
( 7 )Becomes exercisable in equal annual installments of 20% commencing 06/27/2008.
( 8 )Becomes exercisable in equal annual installments of 20% commencing 05/21/2009.
( 9 )Becomes exercisable in equal annual installments of 20% commencing 09/26/2010.
( 10 )Becomes exercisable in equal annual installments of 20% commencing 08/11/2012.

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.